Bvf Inc Argenx Se Transaction History

Bvf Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $85.2 Million - $120 Million	-316,204 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $25.4 Million - $35.1 Million	100,000 Added 46.25%	316,204 $99.7 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $40.8 Million - $53 Million	-150,000 Reduced 40.96%	216,204 $75.7 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $84.1 Million - $99.9 Million	-285,000 Reduced 43.77%	366,204 $111 Million
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $87.8 Million - $109 Million	341,605 Added 110.34%	651,204 $196 Million
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $66.3 Million - $94 Million	247,108 Added 395.43%	309,599 $85.3 Million
Q4 2020 Feb 12, 2021	SELL	$248.13 - $308.36 $26.6 Million - $33 Million	-107,109 Reduced 63.15%	62,491 $18.4 Million
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $47.5 Million - $60.1 Million	-220,400 Reduced 56.51%	169,600 $44.5 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $46.5 Million - $84.9 Million	365,000 Added 1460.0%	390,000 $87.8 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $2.66 Million - $4.11 Million	25,000 New	25,000 $4.01 Million
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $9.3 Million - $11.4 Million	-80,868 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $259,068 - $445,869	4,060 Added 5.29%	80,868 $7.77 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $5.8 Million - $7.42 Million	76,808 New	76,808 $5.83 Million

413

31M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $36.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.